HK Stock Market Move | AOM INT'L (00381) is up more than 10%. The company plans to acquire a 51% stake in Hainan Second Chain Technology.
Quanshi International (00381) rose more than 10%, as of the time of writing, it rose by 11.39%, with a price of 0.44 Hong Kong dollars, and a turnover of 1.5068 million Hong Kong dollars.
AOM INT'L (00381) surged more than 10%, as of the time of writing, it has increased by 11.39%, trading at 0.44 Hong Kong dollars with a transaction volume of 1.5068 million Hong Kong dollars.
In terms of news, AOM INT'L recently announced that the company has entered into a memorandum of understanding with Ms. Wang Fang (the seller), the contracting parties have agreed to negotiate on the possible conditional acquisition by the company and the possible conditional sale by the seller of 51% equity interest in Hainan Miaolian Technology Co., Ltd. (the target company).
It is reported that Hainan Miaolian Technology Co., Ltd., established in 2021, is a professional provider of enterprise digitalization solutions. Its services cover various aspects of enterprise digitalization, including digital strategic planning, business process optimization, data mining, machine learning, cloud computing, and big data.
Related Articles

Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.

Zhejiang Xianju Pharmaceutical (002332.SZ) and related personnel received a warning letter from the Zhejiang Securities Regulatory Bureau.

Maiwei Biology (688062.SH): Application for market approval of 9MW0813 injection has been accepted.
Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.

Zhejiang Xianju Pharmaceutical (002332.SZ) and related personnel received a warning letter from the Zhejiang Securities Regulatory Bureau.

Maiwei Biology (688062.SH): Application for market approval of 9MW0813 injection has been accepted.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025